241 related articles for article (PubMed ID: 25752643)
1. Melatonin as a treatment for gastrointestinal cancer: a review.
Xin Z; Jiang S; Jiang P; Yan X; Fan C; Di S; Wu G; Yang Y; Reiter RJ; Ji G
J Pineal Res; 2015 May; 58(4):375-87. PubMed ID: 25752643
[TBL] [Abstract][Full Text] [Related]
2. The potential therapeutic actions of melatonin in colorectal cancer.
Chok KC; Ng CH; Koh RY; Ng KY; Chye SM
Horm Mol Biol Clin Investig; 2019 May; 39(1):. PubMed ID: 31141480
[TBL] [Abstract][Full Text] [Related]
3. Molecular targets for the management of gastrointestinal cancer using melatonin, a natural endogenous body hormone.
Kohandel Z; Farkhondeh T; Aschner M; Samarghandian S
Biomed Pharmacother; 2021 Aug; 140():111782. PubMed ID: 34087693
[TBL] [Abstract][Full Text] [Related]
4. Melatonin as a potential anticarcinogen for non-small-cell lung cancer.
Ma Z; Yang Y; Fan C; Han J; Wang D; Di S; Hu W; Liu D; Li X; Reiter RJ; Yan X
Oncotarget; 2016 Jul; 7(29):46768-46784. PubMed ID: 27102150
[TBL] [Abstract][Full Text] [Related]
5. Potential role of melatonin in prevention and treatment of lung cancer.
Ngai ZN; Chok KC; Ng KY; Koh RY; Chye SM
Horm Mol Biol Clin Investig; 2022 Dec; 43(4):485-503. PubMed ID: 35728260
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Opportunities in Colorectal Cancer: Focus on Melatonin Antioncogenic Action.
Wu H; Liu J; Yin Y; Zhang D; Xia P; Zhu G
Biomed Res Int; 2019; 2019():9740568. PubMed ID: 31637261
[TBL] [Abstract][Full Text] [Related]
7. Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways.
Pourhanifeh MH; Mehrzadi S; Kamali M; Hosseinzadeh A
Eur J Pharmacol; 2020 Nov; 886():173471. PubMed ID: 32877658
[TBL] [Abstract][Full Text] [Related]
8. Potential role of melatonin in prevention and treatment of leukaemia.
Ng MG; Ng KY; Koh RY; Chye SM
Horm Mol Biol Clin Investig; 2021 Aug; 42(4):445-461. PubMed ID: 34355548
[TBL] [Abstract][Full Text] [Related]
9. Melatonin for the prevention and treatment of cancer.
Li Y; Li S; Zhou Y; Meng X; Zhang JJ; Xu DP; Li HB
Oncotarget; 2017 Jun; 8(24):39896-39921. PubMed ID: 28415828
[TBL] [Abstract][Full Text] [Related]
10. Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved.
Bastani S; Akbarzadeh M; Rastgar Rezaei Y; Farzane A; Nouri M; Mollapour Sisakht M; Fattahi A; Akbarzadeh M; Reiter RJ
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639215
[TBL] [Abstract][Full Text] [Related]
11. Melatonin as a multifunctional anti-cancer molecule: Implications in gastric cancer.
Asghari MH; Moloudizargari M; Ghobadi E; Fallah M; Abdollahi M
Life Sci; 2017 Sep; 185():38-45. PubMed ID: 28739305
[TBL] [Abstract][Full Text] [Related]
12. Melatonin, an inhibitory agent in breast cancer.
Nooshinfar E; Safaroghli-Azar A; Bashash D; Akbari ME
Breast Cancer; 2017 Jan; 24(1):42-51. PubMed ID: 27017208
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy.
Witt-Enderby PA; Radio NM; Doctor JS; Davis VL
J Pineal Res; 2006 Nov; 41(4):297-305. PubMed ID: 17014686
[TBL] [Abstract][Full Text] [Related]
14. A review of melatonin in hepatic ischemia/reperfusion injury and clinical liver disease.
Li Y; Yang Y; Feng Y; Yan J; Fan C; Jiang S; Qu Y
Ann Med; 2014 Nov; 46(7):503-11. PubMed ID: 25033992
[TBL] [Abstract][Full Text] [Related]
15. Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture.
García-Navarro A; González-Puga C; Escames G; López LC; López A; López-Cantarero M; Camacho E; Espinosa A; Gallo MA; Acuña-Castroviejo D
J Pineal Res; 2007 Sep; 43(2):195-205. PubMed ID: 17645698
[TBL] [Abstract][Full Text] [Related]
16. Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.
Reiter RJ; Rosales-Corral SA; Tan DX; Acuna-Castroviejo D; Qin L; Yang SF; Xu K
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420185
[TBL] [Abstract][Full Text] [Related]
17. Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells.
Carbajo-Pescador S; Martín-Renedo J; García-Palomo A; Tuñón MJ; Mauriz JL; González-Gallego J
J Pineal Res; 2009 Nov; 47(4):330-8. PubMed ID: 19817970
[TBL] [Abstract][Full Text] [Related]
18. The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor.
Maroufi NF; Ashouri N; Mortezania Z; Ashoori Z; Vahedian V; Amirzadeh-Iranaq MT; Fattahi A; Kazemzadeh H; Bizzarri M; Akbarzadeh M; Nejabati HR; Faridvand Y; Rashidi MR; Nouri M
Pathol Res Pract; 2020 Oct; 216(10):153226. PubMed ID: 32987338
[TBL] [Abstract][Full Text] [Related]
19. Endogenous stimulators and inhibitors of angiogenesis in gastrointestinal cancers: basic science to clinical application.
Sund M; Zeisberg M; Kalluri R
Gastroenterology; 2005 Dec; 129(6):2076-91. PubMed ID: 16344073
[TBL] [Abstract][Full Text] [Related]
20. The emergence of melatonin in oncology: Focus on colorectal cancer.
Gil-Martín E; Egea J; Reiter RJ; Romero A
Med Res Rev; 2019 Nov; 39(6):2239-2285. PubMed ID: 30950095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
